Lantern Pharma Inc. Deferred Tax Assets, Operating Loss Carryforwards
Lantern Pharma Inc. (LTRN) had Deferred Tax Assets, Operating Loss Carryforwards of $16.09 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $16.09M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $9.35M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $7.38M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.47M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $16.09M 10-K · filed 2026-03-30 |
| 2024-12-31 | $9.35M 10-K · filed 2026-03-30 |
| 2023-12-31 | $7.38M 10-K · filed 2025-03-27 |
| 2022-12-31 | $6.47M 10-K · filed 2024-03-18 |
| 2021-12-31 | $4.84M 10-K · filed 2023-03-20 |
| 2020-12-31 | $2.42M 10-K · filed 2022-03-10 |
| 2019-12-31 | $1.37M 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |